New trial
Phase 1 Trial: HistoSonics Histotripsy (ultrasound cavitation tissue ablation) in advanced colorectal metastases
- Trial ID
- NCT07044362 on ClinicalTrials.gov
- Cancer type
- Colorectal Cancer
- Stage of research
- Exploratory
- Published in
- New in Oncology - July 25, 2025
Investigating whether combining histotripsy with standard palliative chemotherapy improves progression-free survival in patients with unresectable, bilobar colorectal liver metastases, this prospective, single-arm Phase 1 study at Cleveland Clinic and Case Comprehensive Cancer Center evaluates standard chemotherapy alongside histotripsy treatment, with supportive imaging, biopsies, and genetic testing to assess safety and potential enhanced clinical outcomes.
More in colorectal cancer
-
New trial · Oct 15, 2026 · NCT07750158
Phase 3 STELLAR-316 tests zanzalintinib with or without pembrolizumab for ctDNA-positive, scan-negative colorectal cancer -
New trial · Oct 15, 2026 · NCT07842965
Phase 1/1b CHAMP adds CCR5 blockade with leronlimab to surgery, hepatic arterial floxuridine, and systemic therapy for colorectal liver metastases -
New trial · Oct 15, 2026 · NCT07551596
Phase 2 COMBAT tests botensilimab plus balstilimab for ctDNA-positive molecular residual disease in MSS colorectal cancer -
New trial · Oct 8, 2026 · NCT07811193
Phase 2 VVD-133214 WRN helicase covalent inhibitor + pembrolizumab (PD-1 antibody) in MSI/dMMR CRC -
New trial · Oct 8, 2026 · NCT07808151
Phase 2 porustobart CTLA-4 antibody + pembrolizumab PD-1 antibody in resectable MSS colon cancer
